News FDA Approves Tocilizumab (Actemra) for Giant Cell Arteritis by Medscape • 2017/05/22 • 0 Comments The FDA has expanded the approved use of subcutaneous tocilizumab (Actemra, Hoffman LaRoche) to include treatment of adults with giant cell arteritis. FDA Approvals Full Story →